Register entry

TAPI Hungary Industries Kft.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
21
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

21

21 active NDC listings: 21 bulk ingredient. By marketing category: BULK INGREDIENT 21.

Dosage formNDCs
powder21
RouteNDCs
Labeller name on the listingNDCs
tapi hungary industries kft.21
Catalogue

Marketed products

21
BrandGeneric nameForm / routeNDC
-Bicalutamidepowder84671-1028BULK INGREDIENT
-Deferoxamine Mesylatepowder84671-1016BULK INGREDIENT
-FIDAXOMICINpowder84671-1054BULK INGREDIENT
-Imiquimodpowder84671-1030BULK INGREDIENT
-Lovastatinpowder84671-1014BULK INGREDIENT
-Lovastatinpowder84671-1040BULK INGREDIENT
-Midostaurin Amorphpowder84671-1058BULK INGREDIENT
-Mupirocinpowder84671-1017BULK INGREDIENT
-Mupirocin Calciumpowder84671-1046BULK INGREDIENT
-Mycophenolate Sodiumpowder84671-1049BULK INGREDIENT
-ORIPAVINEpowder84671-1062BULK INGREDIENT
-Ondansetronpowder84671-1033BULK INGREDIENT
-Ondansetron Hydrochloridepowder84671-1025BULK INGREDIENT
-Pacritinib Citratepowder84671-1061BULK INGREDIENT
-Pirtobrutinibpowder84671-1060BULK INGREDIENT
-Pravastatin Sodiumpowder84671-1022BULK INGREDIENT
-Simvastatin Micronizedpowder84671-1042BULK INGREDIENT
-Tobramycinpowder84671-1012BULK INGREDIENT
-Tobramycin Micronizedpowder84671-1041BULK INGREDIENT
-Trilaciclib Hemi-Citratepowder84671-1059BULK INGREDIENT
-Zaleplonpowder84671-1026BULK INGREDIENT
Compare

Other companies listing lovastatin

Enquiry

Common questions

Is TAPI Hungary Industries Kft. FDA approved?
TAPI Hungary Industries Kft. holds no registered establishment of its own; 21 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does TAPI Hungary Industries Kft. make?
21 products are listed under TAPI Hungary Industries Kft. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.